卫信康利多卡因丁卡因乳膏临床试验获批

Core Viewpoint - Weitengkang (603676) announced that its wholly-owned subsidiary, Tibet Zhongwei Chengkang Pharmaceutical Co., Ltd., received approval from the National Medical Products Administration for the clinical trial of Lidocaine Dincaine Cream for local anesthesia in adult skin surgeries [1] Group 1 - The approval allows the company to conduct clinical trials for the product, which is intended for local anesthesia on intact skin prior to surgical procedures [1]